Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Rimm

Showing results (121-130 of 412) with videos related to

Pageof 42
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysisHarriet M Kluger, Marisa Dolled-Filhart, Sofya Rodov, et al.
Breast Cancer Research : BCR|November 11, 2005
Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancerSusan A Higgins, Ellen T Matloff, David L Rimm, et al.
Cancer Research|December 18, 2003
Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survivalAaron J Berger, Harriet M Kluger, Ning Li, et al.
Cancer Research|June 29, 2021
Targeting Pyruvate Kinase M2 Phosphorylation Reverses Aggressive Cancer PhenotypesMaria Apostolidi, Ioannis A Vathiotis, Viswanathan Muthusamy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
Evaluating the expression and prognostic value of TRAIL-R1 and TRAIL-R2 in breast cancerMary M McCarthy, Mario Sznol, Kyle A DiVito, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2010
PMCA2 regulates apoptosis during mammary gland involution and predicts outcome in breast cancerJoshua VanHouten, Catherine Sullivan, Caroline Bazinet, et al.
Cell|February 7, 2012
PKCε promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondriaEric Lau, Harriet Kluger, Tal Varsano, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 8, 2021
Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancerSaman Farahmand, Aileen I Fernandez, Fahad Shabbir Ahmed, et al.
Cancer Research|April 6, 2007
High HSP90 expression is associated with decreased survival in breast cancerElah Pick, Yuval Kluger, Jennifer M Giltnane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Bimodal population or pathologist artifact?David L Rimm, Jennifer M Giltnane, Christopher Moeder, et al.
Pageof 42

Showing results (121-130 of 412) with videos related to

Sort By:
Pageof 42
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysisHarriet M Kluger, Marisa Dolled-Filhart, Sofya Rodov, et al.
Breast Cancer Research : BCR|November 11, 2005
Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancerSusan A Higgins, Ellen T Matloff, David L Rimm, et al.
Cancer Research|December 18, 2003
Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survivalAaron J Berger, Harriet M Kluger, Ning Li, et al.
Cancer Research|June 29, 2021
Targeting Pyruvate Kinase M2 Phosphorylation Reverses Aggressive Cancer PhenotypesMaria Apostolidi, Ioannis A Vathiotis, Viswanathan Muthusamy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
Evaluating the expression and prognostic value of TRAIL-R1 and TRAIL-R2 in breast cancerMary M McCarthy, Mario Sznol, Kyle A DiVito, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2010
PMCA2 regulates apoptosis during mammary gland involution and predicts outcome in breast cancerJoshua VanHouten, Catherine Sullivan, Caroline Bazinet, et al.
Cell|February 7, 2012
PKCε promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondriaEric Lau, Harriet Kluger, Tal Varsano, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 8, 2021
Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancerSaman Farahmand, Aileen I Fernandez, Fahad Shabbir Ahmed, et al.
Cancer Research|April 6, 2007
High HSP90 expression is associated with decreased survival in breast cancerElah Pick, Yuval Kluger, Jennifer M Giltnane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Bimodal population or pathologist artifact?David L Rimm, Jennifer M Giltnane, Christopher Moeder, et al.
Pageof 42